[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366594-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366594-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","klf4-in-cancer-chemoresistance-molecular-mechanisms-and-therapeutic-implications","KLF4 in cancer chemoresistance: molecular mechanisms and therapeutic implications","","Chemoresistance is a major obstacle in cancer treatment, often causing treatment failure and disease progression. The transcription factor Krüppel-like factor 4 (KLF4) is highlighted as a pivotal regulator of multiple mechanisms driving chemoresistance. Through complex regulatory networks, KLF4 influences drug efflux, DNA repair, apoptotic signaling, tumor heterogeneity, and cancer cell stemness. Tissue- or cell-type-specific post-translational modification (PTM) of KLF4 further contributes to this resistance. The review summarizes emerging possibilities for understanding KLF4-mediated chemoresistance and supports development of more effective therapeutic interventions.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/klf4-in-cancer-chemoresistance-molecular-mechanisms-and-therapeutic-implications/366594/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/klf4-in-cancer-chemoresistance-molecular-mechanisms-and-therapeutic-implications/366594.png","ImageObject",300,407,{"name":42,"@type":43},"Aldword","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What makes chemoresistance a key challenge in cancer therapy?","Question",{"text":63,"@type":64},"Chemoresistance prevents effective chemotherapy-induced cell death, leading to treatment failure and disease progression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which mechanisms are regulated by KLF4 in cancer chemoresistance?",{"text":68,"@type":64},"KLF4 modulates drug efflux, DNA repair, apoptotic signaling, tumor heterogeneity, and cancer cell stemness through regulatory networks.",{"name":70,"@type":61,"acceptedAnswer":71},"How do post-translational modifications of KLF4 contribute to chemoresistance?",{"text":72,"@type":64},"Tissue- or cell-type-specific PTMs of KLF4 are described as playing a significant role in developing cancer chemoresistance.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366594,1790217668,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},2336478940917,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Review  \nKLF4 in cancer chemoresistance: molecular mechanismsand therapeutic implications  \nSuresh Singh Yadav1 · Punita Kalia1 · Navneet Kaur1 · Sourav Sharma2 · Shambhavi Thakur1 · Soni Kumari3 · Rohini Ravindran Nair2  \nReceived: 21 January 2025 / Accepted: 28 March 2025  \n© The Author(s) 2025 OPEN  \nAbstract  \nChemoresistance is a major obstacle in cancer treatment, and it often results in treatment failure and disease progression. Among the plethora of factors contributing to chemoresistance, the transcription factor Krüppel-like factor 4 (KLF4) has emerged as a pivotal player. This review discusses the role of KLF4 in orchestrating various mechanisms underlying cancer chemoresistance. KLF4, originally identified as a regulator of cell differentiation and proliferation, has recently gained attention for its role in modulating cellular responses to chemotherapeutic agents. Through complex regulatory networks, KLF4 modulates the process of drug efflux, DNA repair, apoptotic signaling, tumor heterogeneity, and cancer cell stemness, leading to the development of cancer chemoresistance. Additionally, tissue or cell types specific posttranslational modification (PTM) of KLF4 plays a significant role in the development of cancer chemoresistance. Thereview explores emerging possibilities and available information that can be utilised to understand the mechanism of chemoresistance mediated by KLF4 in cancer. In conclusion, understanding the complex mechanisms through which KLF4 orchestrates cancer chemoresistance opens promising avenues for developing more effective therapeutic interventions to combat treatment-resistant cancers.  \nKeywords KLF4 · Cancer · Chemoresistance · Drug efflux · DNA repair · Tumor heterogeneity · Post-translational modification  \nAbbreviations  \nABC ATP-binding cassette BP Biological process  \nCAF Cancer-associated fibroblast CC Cellular component  \nCSC Cancer stem cell DBD DNA-binding domain DFO Deferoxamine  \nDFX Deferasirox  \nEGFR Epidermal growth factor receptor EMT Epithelial-mesenchymal transition ER Endoplasmic reticulum  \n* Suresh Singh Yadav, [suresh4bhu@gmail.com |](suresh4bhu@gmail.com |1Department of Molecular Biology and)[1](suresh4bhu@gmail.com |1Department of Molecular Biology and)[Department of Molecular Biology and](suresh4bhu@gmail.com |1Department of Molecular Biology and) Biochemistry, Guru Nanak Dev University, Amritsar, Punjab 143005, India. 2Department of Medical Biotechnology, Gujarat Biotechnology University, Gandhinagar, Gujarat 382355, India. 3Department of Biochemistry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.  \nDiscover Oncology  \n(2025) 16:1690  \n| [https://doi.org/10.1007/s12672-025-02261-4](https://doi.org/10.1007/s12672-025-02261-4)  \nFDA Food and Drug Administration GO Gene ontology  \nHCC Hepatocellular carcinoma HMGB High-mobility group box  \nKEGG Kyoto encyclopedia of genes and genomes MF Molecular function  \nmTORC1 Mechanistic target of rapamycin complex 1 NLS Nuclear localization signal  \nNSCLC Non-small-cell lung cancer PARP Poly (ADP-ribose) polymerase  \nPC Prostate cancer  \nPEST Proline, glutamic acid, serine, threonine  \nPPI Protein–protein interaction PTM Post-translational modification RCC Renal cell carcinoma  \nTAM Tumor-associated macrophage TME Tumor microenvironment TNBC Triple-negative breast cancer UPR Unfolded protein response ZnF Zinc finger  \n1 Introduction  \nDespite significant advancements in cancer treatment, chemoresistance remains a major challenge, limiting the effectiveness of standard chemotherapy regimens. The American Cancer Society estimated the 2,041,910 new cancer cases and 618,120 cancer deaths in the U.S. in 2025. Cancer mortality has steadily declined, preventing nearly 4.5 million deaths since 1991 due to reduced smoking, early detection, and improved treatments, although significant racial disparities persist. While cancer incidence has declined in men, it has risen in women, particularly in those","cbCaipGfxaaJzzVl","https://ap.wps.com/l/cbCaipGfxaaJzzVl","pdf",2906541,14,"English","# Introduction\n## Chemoresistance background and clinical challenge\n## Intrinsic versus acquired chemoresistance mechanisms\n# Role of KLF4 in chemoresistance","[{\"question\":\"What makes chemoresistance a key challenge in cancer therapy?\",\"answer\":\"Chemoresistance prevents effective chemotherapy-induced cell death, leading to treatment failure and disease progression.\"},{\"question\":\"Which mechanisms are regulated by KLF4 in cancer chemoresistance?\",\"answer\":\"KLF4 modulates drug efflux, DNA repair, apoptotic signaling, tumor heterogeneity, and cancer cell stemness through regulatory networks.\"},{\"question\":\"How do post-translational modifications of KLF4 contribute to chemoresistance?\",\"answer\":\"Tissue- or cell-type-specific PTMs of KLF4 are described as playing a significant role in developing cancer chemoresistance.\"}]","KLF4 in cancer chemoresistance: molecular mechanisms and therapeutic implications | PDF",1790166316,35,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/299a2b19aef92ccef1d61afd134ff467.webp",983,1305,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/35787c4ac4907ec378bcdd2f1e045e66.webp",982,1304,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64ffbb1aaa4d8119f91a4cbef5c56768.webp",981,1303,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ae3023de1f59f3ce7e636dacaa206b3.webp",980,1301]